Skip to main content
Log in

Operational Difficulties with Internal Pilot Studies to Update Sample Size

  • Published:
Drug information journal : DIJ / Drug Information Association Aims and scope Submit manuscript

Abstract

Internal pilot studies used for establishing the required sample size for a clinical trial part way through that trial are attractive when one is faced with difficulties in determining underlying variances or underlying event rates. By extrapolating a known curio of post-hoc sample size calculations, it is demonstrated how a sample size calculation may be obtained from a blind internal pilot that increases the study size even though, had a decision been made to stop the study and unblind it, enough information existed to reject the null hypothesis.

The questions of whether to continue recruiting and how much further to recruit may be considered. This will be influenced by the determination of the final (relative to the initial) study size determined from the internal pilot and the current perceived interest in the research question. If a study is stopped at the point of the recalculation, the reasons for the early stopping need to be carefully considered to decide if any bias may result. The decision to stop may be unconditional or conditional on the data. The two cases are distinguished through a variety of examples and their possible biases are considered.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Wittes J, Brittain E. The role of internal pilot studies in increasing the efficiency of clinical trials. Stat Med. 1990;9:65–72.

    Article  CAS  Google Scholar 

  2. Gould AL. Interim analyses for monitoring clinical trials that do not materially affect the Type I error rate. Stat Med. 1992;11:55–66.

    Article  CAS  Google Scholar 

  3. Birkett MA, Day SJ. Internal pilot studies for estimating sample size. Stat Med. 1990;13:2455–2463.

    Article  Google Scholar 

  4. Sandvik L, Erikssen J, Mowinckel P, Rødland EA. A method for determining the size of internal pilot studies. Stat Med. 1996;15:1587–1590.

    Article  CAS  Google Scholar 

  5. Denne JS, Jennison C. Estimating the sample size for a t-test using an internal pilot. Stat Med. 1999;18:1575–1585.

    Article  CAS  Google Scholar 

  6. Wittes J, Schabenberger O, Zucker D, Brittain E, Proschan M. Internal pilot studies I: type I error rate of the naive t-test. Stat Med. 1999;18:3481–3491.

    Article  CAS  Google Scholar 

  7. Zucker DM, Wittes JT, Schabenberger O, Brittain E. Internal pilot studies II: comparison of various procedures. Stat Med. 1999;18:3493–3509.

    Article  CAS  Google Scholar 

  8. Proschan MA, Hunsberger SA. Designed extension of studies based on conditional power. Biometrics. 1995;51:1315–1324.

    Article  CAS  Google Scholar 

  9. Xamoterol in Severe Heart Failure Study Group. Xamoterol in severe heart failure. The Lancet. 1990;336:1–6.

    Article  Google Scholar 

  10. Lehr R. Sixteen 5-squared over D-squared: a relation for crude sample size estimates. Stat Med. 1992;11:1099–1102.

    Article  CAS  Google Scholar 

  11. Pocock SJ. Group sequential methods in the design and analysis of clinical trials. Biometrika. 1977;64:191–199.

    Article  Google Scholar 

  12. Pocock SJ. Interim analyses for randomized clinical trials: the group sequential approach. Biometrics. 1982;38:153–162.

    Article  CAS  Google Scholar 

  13. Smith R, Roberts I. An amnesty for unpublished trials. Br Med J. 1997;315:622.

    Article  Google Scholar 

  14. Day S. Practical issues with internal pilot studies. Proceedings of the 15th meeting of the International Society for Clinical Biostatistics. Basle, 1994.

    Google Scholar 

  15. Day S. Optimal placebo response rates for comparing two binomial proportions. Stat Med. 1988;7:1187–1194.

    Article  CAS  Google Scholar 

  16. Wiles A, Atkinson G, Huson L, Morse P, Struthers L. Good statistical practice in clinical research: guideline standard operating procedures. Drug Inf J. 1994;28:615–628.

    Article  Google Scholar 

  17. North PM. Ensuring good statistical practice in clinical research: guidelines for standard operating procedures (an update). Drug Inf J. 1998;32:665–682.

    Article  Google Scholar 

  18. Ellenberg S, Geller N, Simon R, Yusuf S (Eds.) Proceeding of the meeting on practical issues in data monitoring of clinical trials. Stat Med. 1993;12:415–616.

  19. Peace KE, (Ed). Biopharmaceutical Sequential Statistical Applications. New York: Marcel Dekker; 1992.

    Google Scholar 

  20. Day S. Book review. Stat Med. 1993;12:2059.

    Article  Google Scholar 

  21. Whitehead J. On being a statistician on a data and safety monitoring board. Stat Med. 1999;18:3425–3433.

    Article  CAS  Google Scholar 

  22. Peace KE. Discussion for interim analysis and sample size reestimation. Drug Inf J. 1993;27:765–769.

    Article  Google Scholar 

  23. Herson J, Wittes J. The use of interim analysis for sample size adjustment. Drug Inf J. 1993;27:753–760.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Simon Day BSc CStat.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Day, S. Operational Difficulties with Internal Pilot Studies to Update Sample Size. Ther Innov Regul Sci 34, 461–468 (2000). https://doi.org/10.1177/009286150003400215

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1177/009286150003400215

Key Words

Navigation